In our study, PSMD1 and PSMD3 mRNA expression was markedly upregulated in patients who had progressed from the indolent chronic phase to the rapidly fatal blast phase of CML. Here, PSMD1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.